PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients / Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cattina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G.. - In: CANCER RESEARCH. - ISSN 0008-5472. - STAMPA. - 72:8(2012), pp. 4619-4619. (Intervento presentato al convegno AACR 2012 Annual Meeting tenutosi a Chicago nel 30 March - 04 April 2012) [10.1158/1538-7445.AM2012-4619].
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients
PAPAYANNIDIS, CRISTINA;GUADAGNUOLO, VIVIANA;IACOBUCCI, ILARIA;DURANTE, SANDRA;TERRAGNA, CAROLINA;OTTAVIANI, EMANUELA;ABBENANTE, MARIACHIARA;CATTINA, FEDERICA;SOVERINI, SIMONA;LAMA, BARBARA;TONI, LUCIA;BALDAZZI, CARMEN;CURTI, ANTONIO;BACCARANI, MICHELE;MARTINELLI, GIOVANNI
2012
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
